Premium
A funding model for public‐good clinical trials
Author(s) -
Winship Ingrid M,
McNeil John,
Simes R John
Publication year - 2013
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja13.10381
Subject(s) - library science , public health , executive director , citation , medicine , management , nursing , computer science , economics
Perspective next 1 to 2 years through savings in thromboembolism treatment costs. Lipid lowering with statin drugs has reduced cardiovascular mortality and morbidity, espec over the past decade. Its efficacy and cost-effectivenes were demonstrated particularly in the LIPID trial for patients with coronary heart disease and average cholesterol levels, leading to Pharmaceutical Benefits The cost of clinical trials is rising but is still much less than the cost of not doing trials